Home/Filings/8-K/0001493152-26-000558
8-K//Current report

SELECTIS HEALTH, INC. 8-K

Accession 0001493152-26-000558

$GBCSCIK 0000727346operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 1:20 PM ET

Size

199.3 KB

Accession

0001493152-26-000558

Research Summary

AI-generated summary of this filing

Updated

Selectis Health, Inc. Appoints Two Directors to Board

What Happened
Selectis Health, Inc. (filed via Form 8-K on January 6, 2026, Item 5.02) announced that, effective January 1, 2026, the Board approved the appointments of Kent J. Lund (age 70) and Lance Baller (age 51) as members of the Company’s Board of Directors. The filing provides biographical information for each new director.

Key Details

  • Appointments effective January 1, 2026; 8-K filed January 6, 2026 under Item 5.02 (director appointments).
  • Kent J. Lund, 70: longtime legal and securities professional; former member of the Colorado Securities Board (2017–2020), member of FINRA West Region Committee (Jan 2020–Dec 31, 2025), and Independent Board member/audit committee member of JAB Wireless, Inc. (Nov 2018–Jul 2022). Holds B.A. (magna cum laude), J.D. (with honors), M.B.A., and LL.M. in Entrepreneurial Law.
  • Lance Baller, 51: co‑founder and non‑executive Chairman of Iofina Plc; served as CFO (2007–2010) and CEO (2010–2013) of Iofina; served as CEO, Interim CEO, and Director of Selectis Health from 2015–2023; currently involved in multiple private businesses and serves on several public and municipal boards and as audit committee chair/financial expert for certain trusts and funds.

Why It Matters
The board additions bring directors with experience in securities regulation, corporate governance, capital markets and prior Selectis leadership. Investors should note the effective date (Jan 1, 2026) and the backgrounds disclosed; the filing does not provide additional detail on compensation, committee assignments, or departures beyond the appointments.